|
|
 | | | |
- close
- close
- close
- close
StreetInsider.com
May 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cambrex+Corp.+%28CBM%29+Tops+Q1+EPS+by+14c/8303031.html for the full story.
StreetInsider.com
Nov 30
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Longbow+Research+Upgrades+Cambrex+Corporation+%28CBM%29+to+Buy/7913652.html for the full story.
StreetInsider.com
Nov 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cambrex+Corp.+%28CBM%29+Misses+Q3+EPS+by+5c/7845948.html for the full story.
Forbes
Oct 4
Comment
Cambrex (CBM) reached a new 52-week high of $13.44 on September 10, about a month after reporting strong second-quarter results that included a 50% earnings surprise and a raised guidance for the full year.
Forbes
Aug 21
Comment
Cambrex Corporation (CBM - Snapshot Report) has watched its earnings momentum jump since this life sciences company reported strong second quarter results on August 1., Furthermore, the Zacks #1 Rank (Strong Buy) hit its 52-week high of $12.41 on...
StreetInsider.com
Aug 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cambrex+Corp.+%28CBM%29+Tops+Q2+EPS+by+11c/7623445.html for the full story.
Benzinga
Jun 26
Comment
Supernus Pharmaceuticals (NASDAQ: SUPN) shares jumped 70.75% to create a new 52-week high of $9.75. Supernus Pharmaceuticals received a tentative approval letter from the FDA for Trokendi XR(TM).
News Corp (NASDAQ: NWSA) shares gained 7.59% to...
StreetInsider.com
May 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cambrex+Corp.+%28CBM%29+Tops+Q1+EPS+by+10c/7402115.html for the full story.
Benzinga
Feb 6
Comment
Cambrex Corporation (NYSE: CBM) currently expects that full year 2012 sales, excluding the impact of foreign currency, will increase between 2% and 6% versus 2011, and that full year 2012 EBITDA, defined as operating profit plus depreciation and...
Benzinga
Feb 6
Comment
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
